Parkin and α-synuclein:: Opponent actions in the pathogenesis of Parkinson's disease

被引:7
|
作者
Baptista, MJ [1 ]
Cookson, MR [1 ]
Miller, DW [1 ]
机构
[1] NIA, Neurogenet Lab, NIH, Bethesda, MD 20892 USA
关键词
Lewy bodies; mitochondria; parkin; proteasome; synapses; synuclein;
D O I
10.1177/1073858403260392
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Dominant mutations in the gene for alpha-synuclein, a small presynaptic protein, can cause Parkinson's disease. Although there is still substantial debate about the precise mechanisms, alpha-synuclein is toxic to vulnerable neurons, probably as a result of its tendency to aggregate. Opposing this is another gene product that, when mutated, causes a recessive form of parkinsonism, parkin. Parkin has been recently shown to protect cells against alpha-synuclein toxicity. However, the precise details of the mechanism are unclear. This review will discuss the concept that there are multiple neuronal functions that are targeted by mutant alpha-synuclein, and in many cases, there is evidence that parkin can protect cells against damage to the same systems. The authors will also discuss ways in which to test some of these ideas, by using newly identified genes such as DJ-1 that cause similar phenotypes.
引用
收藏
页码:63 / 72
页数:10
相关论文
共 50 条
  • [41] Pathogenesis of Parkinson's Disease
    Hirsch, Etienne C.
    Jenner, Peter
    Przedborski, Serge
    MOVEMENT DISORDERS, 2013, 28 (01) : 24 - 30
  • [42] Multitasking guardian of mitochondrial quality: Parkin function and Parkinson's disease
    Kamienieva, Iryna
    Duszynski, Jerzy
    Szczepanowska, Joanna
    TRANSLATIONAL NEURODEGENERATION, 2021, 10 (01)
  • [43] Extracellular Alpha-Synuclein Oligomers Induce Parkin S-Nitrosylation: Relevance to Sporadic Parkinson’s Disease Etiopathology
    Anna Wilkaniec
    Anna M. Lenkiewicz
    Grzegorz A. Czapski
    Henryk M. Jęśko
    Wojciech Hilgier
    Robert Brodzik
    Magdalena Gąssowska-Dobrowolska
    Carsten Culmsee
    Agata Adamczyk
    Molecular Neurobiology, 2019, 56 : 125 - 140
  • [44] Pathogenesis of Parkinson's disease
    Schapira, AHV
    BAILLIERES CLINICAL NEUROLOGY, 1997, 6 (01): : 15 - 36
  • [45] Rho GTPase regulation of α-synuclein and VMAT2: Implications for pathogenesis of Parkinson's disease
    Zhou, Zhigang
    Kim, Jeeyong
    Insolera, Ryan
    Peng, Xiangmin
    Fink, David J.
    Mata, Marina
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2011, 48 (01) : 29 - 37
  • [46] CpG Demethylation Enhances Alpha-Synuclein Expression and Affects the Pathogenesis of Parkinson's Disease
    Matsumoto, Lumine
    Takuma, Hiroshi
    Tamaoka, Akira
    Kurisaki, Hiroshi
    Date, Hidetoshi
    Tsuji, Shoji
    Iwata, Atsushi
    PLOS ONE, 2010, 5 (11):
  • [47] A yeast model of the Parkinson's disease-associated protein Parkin
    Pereira, Clara
    Costa, Vitor
    Miguel Martins, L.
    Saraiva, Lucilia
    EXPERIMENTAL CELL RESEARCH, 2015, 333 (01) : 73 - 79
  • [48] Multitasking guardian of mitochondrial quality: Parkin function and Parkinson’s disease
    Iryna Kamienieva
    Jerzy Duszyński
    Joanna Szczepanowska
    Translational Neurodegeneration, 10
  • [49] α-Synuclein Ubiquitination and Novel Therapeutic Targets for Parkinson's Disease
    Rott, Ruth
    Szargel, Raymonde
    Shani, Vered
    Bisharat, Sleman
    Engelender, Simone
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (04) : 630 - 637
  • [50] Potential direct role of synuclein in dopamine transport and its implications for Parkinson's disease pathogenesis
    Kim, Meewhi
    Bezprozvanny, Ilya
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2023, 671 : 18 - 25